Please help support Alcohol & Drug Services in your local community

Probuphine for Opioid Addiction

Tuesday, 16 August 2016 by

Probuphine is a new drug recently developed and released by Braeburn Pharmaceuticals. The drug is FDA-approved and is a time-released version of buprenorphine (the active ingredient in Suboxone that staves off opioid withdrawal symtoms). Probuphine must be implanted beneath the patient’s skin (typically in the arm) where it gradually distributes medication for 6 months. The

TOP